anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
BioAtla · pitchdeck

BioAtla | Investor Presentation Deck | 37 slides

37 pages · 5 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

BioAtla | Investor Presentation Deck | 37 slides

BioAtla · 2022-08
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 29 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Market Sizing 8 slides 100% 8/8 slides 100% 8/8 slides · 46 hits
— 0/8 slides
37.5% 3/8 slides 25% 2/8 slides 100% 8/8 slides · 15 hits 87.5% 7/8 slides Traction 18 slides 100% 18/18 slides 100% 18/18 slides · 98 hits
— 0/18 slides
55.6% 10/18 slides 5.6% 1/18 slides 100% 18/18 slides · 25 hits 100% 18/18 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

37
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a linked-circle diagram to represent the company's core value propositions.summarize
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The slide uses a 2x5 grid layout to display 10 team members.other
Open slide detailBeat · Team
05
The slide uses a comparative visual framework to contrast healthy cells (no binding) with cancer cells (CAB binding).present_solution
Open slide detailBeat · Solution
06
The slide uses a three-column layout to categorize the platform's therapeutic modalities.present_solution
Open slide detail
07
The slide uses a Gantt-style visualization to show the progression of drug candidates through clinical phases.plan_implementation
Open slide detail
08
transition
Open slide detail
09
Uses a comparative framework to highlight unmet medical needs in two specific cancer indications.size_opportunity
Open slide detailBeat · Market Sizing
10
Includes waterfall plot for partial response and spider plot for longitudinal tumor change.show_traction
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
11
The slide uses a process-flow diagram to map patient cohorts to clinical outcomes and subsequent study advancement decisions.show_traction
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
12
Includes a spider plot for lesion change and a Kaplan-Meier survival curve.show_traction
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
13
Includes Kaplan-Meier survival curve and waterfall plot for lesion change.show_traction
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
14
Clinical trial data showing PFS at 3 months for Liposarcoma and Synovial Sarcoma cohorts.show_traction
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
15
Includes specific clinical trial terminology (CTCAE, SAE, RP2D, Q2W).show_traction
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
16
The slide uses a grid of metrics to establish the total addressable market and clinical benchmarks.size_opportunity
Open slide detailBeat · Market SizingLoop · Quick Win Big Bet
17
The chart is a waterfall plot showing maximum change from baseline for different patient cohorts.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
18
The slide uses a process-oriented layout to describe clinical trial phases.plan_implementation
Open slide detailBeat · TractionLoop · Quick Win Big Bet
19
Clinical trial data for BA3011 in NSCLC patients.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
20
Clinical trial data presentation for oncology drug candidate.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
21
The slide serves as a section divider for a deep dive into a specific therapeutic platform.transition
Open slide detailBeat · TractionLoop · Quick Win Big Bet
22
The slide uses a grid of metrics to define the total addressable market and the specific target segment.size_opportunity
Open slide detailBeat · TractionLoop · Quick Win Big Bet
23
The chart is a waterfall plot showing percentage change in tumor size for individual patients.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
24
The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population and success threshold data.size_opportunity
Open slide detailBeat · TractionLoop · Quick Win Big Bet
25
The chart displays longitudinal data for two specific patients, showing sustained complete response.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
26
SCCHN = Squamous Cell Carcinoma of the Head and Neck. ROR2 is the target biomarker.size_opportunity
Open slide detailBeat · TractionLoop · Quick Win Big Bet
27
The slide uses a table to present clinical outcomes for specific tumor types, emphasizing the first-in-class potential of the therapy.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
28
The slide uses a process-oriented layout to describe clinical trial phases.plan_implementation
Open slide detail
29
transition
Open slide detail
30
The slide uses a combination of a comparison table for clinical data and a dot plot for NHP toxicity data.compare_peers
Open slide detail
31
The slide uses a timeline-based visual to show dose escalation steps leading to RP2D selection.plan_implementation
Open slide detail
32
transition
Open slide detail
33
The chart shows tumor volume over time for three different antibody treatments, with the CAB-EpCAM x CAB-CD3 showing the best efficacy.show_traction
Open slide detail
34
The slide uses a timeline-based table structure to map programs to specific clinical milestones.plan_implementation
Open slide detailLoop · Why Now
35
Uses a linked-circle diagram to represent interconnected business pillars.summarize
Open slide detail
36
appendix
Open slide detail
37
other
Open slide detail